Loading clinical trials...
Loading clinical trials...
This study will evaluate the safety and immune response to GlaxoSmithKline Tdap vaccine compared to licensed Td vaccine when used as a booster in healthy adolescents (10-18 years of age).
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
GlaxoSmithKline
NCT07107932 · Tetanus
NCT07203755 · Diphtheria, Tetanus and Acellular Pertussis, Epidemic Meningitis, and more
NCT07112144 · Prevent Whooping Cough, Prevent Diphtheria, and more
NCT06947499 · Diphtheria, Tetanus, and more
NCT07149454 · Tetanus
GSK Investigational Site
Mesa, Arizona
GSK Investigational Site
Tempe, Arizona
GSK Investigational Site
Jonesboro, Arkansas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions